K2 HealthVentures is a flexible provider of debt and equity capital to venture and growth stage companies in the life sciences and healthcare industries.
Location: United States, Massachusetts, Boston
Investment Type: Venture Capital
Investment Stage: Series B; Debt
Portfolio 28
| Date | Name | Website | Total Raised | Location |
| 10.02.2023 | Alignment ... | alignmenthealth.com | $135M | United Sta... |
| 05.01.2023 | 89bio | 89bio.com | $60M | - |
| 27.12.2022 | Alto Neuro... | altoneuroscience.com | $140M | United Sta... |
| 27.11.2022 | DispatchHe... | dispatchhealth.com | $1.01B | United Sta... |
| - | Inari | inari.com | $774M | United Sta... |
| - | Aptinyx In... | aptinyx.com | $135M | United Sta... |
| - | PlateletBi... | plateletbio.com | - | United Sta... |
| - | Companion ... | companionmedical.com | - | - |
| - | Corbus Pha... | corbuspharma.com | $25M | United Sta... |
| - | Hopscotch ... | hellohopscotch.com | - | United Sta... |
Show more
Mentions in press and media 8
| Date | Title | Description |
| 20.01.2025 | Umoja Biopharma's $100 Million Leap: A New Era for In Vivo CAR T Cell Therapies | Umoja Biopharma is on the rise. The Seattle-based company has just secured $100 million in Series C financing. This is not just a number; it’s a statement. It signals a bold step forward in the world of biotechnology. The funding round was ... |
| 20.01.2025 | Umoja Biopharma Raises $100M in Series C Financing | Umoja Biopharma, a Seattle, WA-based clinical-stage company which specializes in vivo cell therapies, raised $100M Series C financing. The round was led by Double Point Ventures and DCVC Bio, with participation from new and existing investo... |
| 29.11.2022 | DispatchHealth Looks To Expand In-home Care With More Than $330M in Financing | About $4 trillion is spent annually on the healthcare industry in the U.S., and will likely top $6 trillion by 2028. A large chunk of this money is for care in traditional brick and mortar facilities, said DispatchHealth CEO Dr. Mark Prathe... |
| 28.07.2022 | Elevation Oncology Secures $50M Loan Facility with K2 HealthVentures | What You Should Know: Elevation Oncology, a clinical-stage biopharmaceutical company focused on the development of precision oncology products for patients with genomically defined cancers, today announced that it has secured a $50M senior ... |
| 13.07.2021 | ASLAN Pharmaceuticals : Announces Loan Facility Providing Up to $45 Million From K2 HealthVentures | SINGAPORE, July 13, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that it has... |
| 13.07.2021 | ASLAN Pharmaceuticals Announces Loan Facility Providing Up to $45 Million From K2 HealthVentures | ASLAN Pharmaceuticals Limited announced that it has closed a secured loan facility provided by K2 HealthVentures (K2HV). Under the terms of the facility, K2HV will provide ASLAN up to $45 million of secured debt financing. The facility cons... |
| 08.05.2021 | Cricket Health Secures $83.5M to Expand Value-Based Kidney Care Model to Health Plans | What You Should Know: – Cricket Health, a San Francisco, CA-based provider of value-based kidney care with a clinically-proven approach to managing chronic kidney disease (CKD) and end-stage kidney disease (ESKD), today announced it has rai... |
| 23.05.2019 | K2 HealthVentures Launches New Investment Firm | K2 HealthVentures (K2HV) has launched a new specialty finance firm that will provide long-term debt, equity, and intellectual capital to private and public life sciences and healthcare companies. With $400M initial capital commitment, which... |